CaseReport
Clarithromycin-Associated Acute Liver Failure Leading to Fatal,
Massive Upper Gastrointestinal Hemorrhage from Profound
Coagulopathy: Case Report and Systematic Literature Review
Ahmed I. Edhi,
1
Seifeldin Hakim,
1
Christienne Shams ,
2
Damanpreet Bedi,
3
Mitual Amin,
4
and Mitchell S. Cappell
1,5
1
DivisionofGastroenterology&Hepatology,DepartmentofMedicine,WilliamBeaumontHospital,3535WirteenMileRd,
RoyalOak,MI48073,USA
2
DepartmentofMedicine,WilliamBeaumontHospital,OaklandUniversityWilliamBeaumontSchoolofMedicine,
3535WirteenMileRd,RoyalOak,MI48073,USA
3
TransplantSurgery,DepartmentofSurgery,WilliamBeaumontSchoolofMedicine,3601WirteenMileRd,RoyalOak,
MI48073,USA
4
DepartmentofPathology,WilliamBeaumontHospital,OaklandUniversityWilliamBeaumontSchoolofMedicine,
3601WirteenMileRd,RoyalOak,MI48073,USA
5
DivisionofGastroenterology&Hepatology,DepartmentofMedicine,
OaklandUniversityWilliamBeaumontSchoolofMedicine,3535WirteenMileRd,RoyalOak,MI48073,USA
Correspondence should be addressed to Mitchell S. Cappell; mitchell.cappell@beaumont.edu
Received 9 July 2019; Accepted 13 January 2020; Published 18 February 2020
Academic Editor: Sorabh Kapoor
Copyright©2020AhmedI.Edhietal.isisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
While erythromycin has caused numerous cases of acute liver failure (ALF), clarithromycin, a similar macrolide antibiotic, has
caused only six reported cases of ALF. A new case of clarithromycin-associated ALF is reported with hepatic histopathology and
exclusion of other etiologies by extensive workup, and the syndrome of clarithromycin-associated ALF is better characterized by
systematic review. A 60-year-old nonalcoholic man, with normal baseline liver function tests, was admitted with diffuse ab-
dominal pain and AST � 499 /L and ALT � 539 /L, six days after completing a 7-day course of clarithromycin 500 mg twice
daily for suspected upper respiratory infection. AST and ALT each rose to about 1,000 /L on day-2 of admission, and rose to
≥6,000 /L on day-3, with development of severe hepatic encephalopathy and severe coagulopathy. Planned liver biopsy was
cancelled due to coagulopathies. Extensive evaluation for infectious, immunologic, and metabolic causes of liver disease was
negative. Abdominal computerized tomography and abdominal ultrasound with Doppler were unremarkable. e patient
developed massive, acute upper gastrointestinal bleeding associated with coagulopathies. Esophagogastroduodenoscopy was
planned after massive blood product transfusions, but the patient rapidly expired from hemorrhagic shock. Autopsy revealed a
golden-brown heavy liver with massive hepatic necrosis and sinusoidal congestion. Rise of AST/ALT to about 1,000 /L each was
temporally incompatible with shock liver because this rise preceded the hemorrhagic shock, but the subsequent AST/ALT rise to
≥6,000 /L each may have had a component of shock liver. e six previously reported cases were limited by failure to exclude
hepatitis E (4), lack of liver biopsy (2), and uninterpretable liver biopsy (1) and by confounding potential etiologies including
disulfiram, israpidine, or recent acetaminophen use (3), clarithromycin overdose (1), active alcohol use (1), and severe heart failure
(1). Review of 6 previously reported and current case of clarithromycin-associated ALF revealed that patients had ASTand ALT
values in the thousands. Five patients died and 2 survived.
Hindawi
Case Reports in Hepatology
Volume 2020, Article ID 2135239, 7 pages
https://doi.org/10.1155/2020/2135239